Lifevantage Price to Book Ratio 2010-2022 | LFVN
Historical price to book ratio values for Lifevantage (LFVN) over the last 10 years. The current price to book ratio for Lifevantage as of March 24, 2023 is 1.38.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Lifevantage Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2023-03-24 |
3.53 |
|
1.41 |
| 2022-12-31 |
3.69 |
$2.51 |
1.47 |
| 2022-09-30 |
3.69 |
$2.54 |
1.45 |
| 2022-06-30 |
4.25 |
$2.52 |
1.68 |
| 2022-03-31 |
4.62 |
$2.71 |
1.71 |
| 2021-12-31 |
6.13 |
$2.71 |
2.26 |
| 2021-09-30 |
6.57 |
$2.82 |
2.33 |
| 2021-06-30 |
7.13 |
$2.70 |
2.64 |
| 2021-03-31 |
9.07 |
$2.55 |
3.56 |
| 2020-12-31 |
9.04 |
$2.51 |
3.60 |
| 2020-09-30 |
11.70 |
$2.40 |
4.88 |
| 2020-06-30 |
13.11 |
$2.32 |
5.64 |
| 2020-03-31 |
9.99 |
$2.00 |
4.99 |
| 2019-12-31 |
15.14 |
$2.04 |
7.44 |
| 2019-09-30 |
13.29 |
$2.11 |
6.29 |
| 2019-06-30 |
12.59 |
$1.93 |
6.53 |
| 2019-03-31 |
13.86 |
$1.73 |
8.02 |
| 2018-12-31 |
12.79 |
$1.47 |
8.68 |
| 2018-09-30 |
10.66 |
$1.67 |
6.39 |
| 2018-06-30 |
6.18 |
$1.56 |
3.96 |
| 2018-03-31 |
3.50 |
$1.35 |
2.59 |
| 2017-12-31 |
4.62 |
$1.16 |
3.97 |
| 2017-09-30 |
4.09 |
$1.11 |
3.69 |
| 2017-06-30 |
4.20 |
$1.02 |
4.11 |
| 2017-03-31 |
5.21 |
$0.98 |
5.33 |
| 2016-12-31 |
7.90 |
$1.03 |
7.65 |
| 2016-09-30 |
9.17 |
$1.00 |
9.16 |
| 2016-06-30 |
13.19 |
$0.76 |
17.37 |
| 2016-03-31 |
8.82 |
$0.63 |
13.98 |
| 2015-12-31 |
9.23 |
$0.50 |
18.43 |
| 2015-09-30 |
5.50 |
$0.33 |
16.79 |
| 2015-06-30 |
3.60 |
$0.24 |
15.10 |
| 2015-03-31 |
5.36 |
$0.20 |
26.26 |
| 2014-12-31 |
8.82 |
$0.32 |
27.41 |
| 2014-09-30 |
7.74 |
$0.50 |
15.49 |
| 2014-06-30 |
9.77 |
$0.27 |
35.77 |
| 2014-03-31 |
8.89 |
$0.18 |
48.46 |
| 2013-12-31 |
11.20 |
$-0.04 |
-303.53 |
| 2013-09-30 |
16.16 |
$2.09 |
7.75 |
| 2013-06-30 |
15.75 |
$2.03 |
7.76 |
| 2013-03-31 |
15.95 |
$2.15 |
7.42 |
| 2012-12-31 |
14.87 |
$2.16 |
6.90 |
| 2012-09-30 |
23.28 |
$2.12 |
11.00 |
| 2012-06-30 |
19.21 |
$1.80 |
10.69 |
| 2012-03-31 |
25.52 |
$1.44 |
17.68 |
| 2011-12-31 |
9.71 |
$0.65 |
14.84 |
| 2011-09-30 |
10.18 |
$-1.14 |
-8.91 |
| 2011-06-30 |
10.18 |
$-1.47 |
-6.91 |
| 2011-03-31 |
4.82 |
|
0.00 |
| 2010-12-31 |
2.65 |
|
0.00 |
| 2010-09-30 |
3.39 |
|
0.00 |
| 2010-06-30 |
3.46 |
|
0.00 |
| 2010-03-31 |
2.65 |
|
0.00 |
| 2009-12-31 |
1.70 |
|
0.00 |
| 2009-09-30 |
2.61 |
|
0.00 |
| 2009-06-30 |
4.55 |
|
0.00 |
| 2009-03-31 |
5.26 |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.045B |
$0.206B |
|
Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt Lake City, Utah.
|
